Yukihiro Tambe
Otsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bacterial growth in breast milk expressed under hygienic control: a pilot study.
Journal: BMC research notes
Published: September 22, 2023
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
Journal: International journal of oncology
Published: March 14, 2022
Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Journal: International journal of oncology
Published: December 24, 2020
Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
Journal: Molecular carcinogenesis
Published: January 30, 2019
Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Journal: International journal of oncology
Published: August 28, 2017
Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer.
Journal: Oncology letters
Published: September 25, 2015
Akt-dependent activation of Erk by cyclin D1b contributes to cell invasiveness and tumorigenicity.
Journal: Oncology letters
Published: May 09, 2015
The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase-B.
Journal: Molecular carcinogenesis
Published: June 05, 2014
Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
Journal: Carcinogenesis
Published: August 27, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026